References:
1. Shim A, Song J-H, Kwon B-E, Lee J-J, Ahn J-H, Kim Y-J, et al.
Therapeutic and prophylactic activity of itraconazole against human
rhinovirus infection in a murine model. Scientific reports.
2016;6:23110. doi:10.1038/srep23110
2. Steel HC, Tintinger GR, Theron AJ, Anderson R. Itraconazole‐mediated
inhibition of calcium entry into platelet‐activating factor‐stimulated
human neutrophils is due to interference with production of leukotriene
B4. Clinical & Experimental Immunology. 2007;150(1):144-50.
doi:10.1111/j.1365-2249.2007.03470.x
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The
lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
4. Schloer S, Goretzko J, Kühnl A, Brunotte L, Ludwig S, Rescher U. The
clinically licensed antifungal drug itraconazole inhibits influenza
virus in vitro and in vivo. Emerging microbes & infections.
2019;8(1):80-93. doi:10.1080/22221751.2018.1559709
5. Trznadel-Grodzka E, Błaszkowski M, Rotsztejn H. Investigations of
seborrheic dermatitis. Part II. Influence of itraconazole on the
clinical condition and the level of selected cytokines in seborrheic
dermatitis. Advances in Hygiene & Experimental Medicine/Postepy Higieny
i Medycyny Doswiadczalnej. 2012;66. doi:10.5604/17322693.1019648
6. Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of
therapeutic targets for SARS-CoV-2 and discovery of potential drugs by
computational methods. Acta Pharmaceutica Sinica B. 2020.
doi:10.1016/j.apsb.2020.02.008
7. Liu W, Morse JS, Lalonde T, Xu S. Learning from the past: possible
urgent prevention and treatment options for severe acute respiratory
infections caused by 2019‐nCoV. Chembiochem. 2020.
doi:10.1002/cbic.202000047
8. Chu CK, Gadthula S, Chen X, Choo H, Olgen S, Barnard DL, et al.
Antiviral activity of nucleoside analogues against SARS-coronavirus
(SARS-CoV). Antiviral Chemistry and Chemotherapy. 2006;17(5):285-9.
doi:10.1177/095632020601700506
9. Puerta-Arias JD, Pino-Tamayo PA, Arango JC, Salazar-Peláez LM,
González A. Itraconazole in combination with neutrophil depletion
reduces the expression of genes related to pulmonary fibrosis in an
experimental model of paracoccidioidomycosis. Medical mycology.
2018;56(5):579-90. doi:10.1093/mmy/myx087
10. Jesus FP, Ferreiro L, Loreto ÉS, Pilotto MB, Ludwig A, Bizzi K, et
al. In vitro synergism observed with azithromycin, clarithromycin,
minocycline, or tigecycline in association with antifungal agents
against Pythium insidiosum. Antimicrobial agents and chemotherapy.
2014;58(9):5621-5.doi:10.1128/AAC.02349-14